1. Home /
  2. Pharmaceuticals


A Rally to $21 on Takeda Pharmaceutical Would Be Bullish

Let's review the charts and indicators.

Charting the Stocks of 3 Covid Treatment Companies

Let's take a close look at Gilead Sciences, Regeneron and Eli Lilly.

Corbus Pharmaceuticals Is an Example of How I'm Playing an Uncertain Market

CRBP has topline Phase 3 data for its primary compound Lenabasum for Systemic Sclerosis due out this summer.

Caution Signs, Laboring Labor Market, Gold Watch and Ugly Intel: Market Recon

Plus, why shares of vaccine maker Moderna are taking a hit.

This Dividend Aristocrat Offers More Than a Band-Aid for Investors

Walgreens Boots Alliance lets you collect 4.6% dividend yield, while you wait for the turnaround.

Sorrento Therapeutics Has Made a Large Base Formation - Timing Is Key

The question is when to buy and what to risk.

Incyte Could Rise Another 15% From Here

Shares of biopharmaceutical manufacturer are close to an upside breakout.

AstraZeneca Could Continue to Higher Highs

Oxford University, along with Britain's AstraZeneca, published promising data from an early stage trial of a key coronavirus vaccine study Monday in London.

Let's Take Another Look at the Charts and Indicators of CVS Health

If you are long CVS continue to hold.

Taking a Wait and Watch Strategy on Biohaven Pharmaceutical

BHVN has made a relatively big advance since April and a period of consolidation or sideways price action is probably likely at this time.